Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful eradication of central nervous system infiltration of primary plasma cell leukemia by temozolomide.

Literature DB >> 35969250

Successful eradication of central nervous system infiltration of primary plasma cell leukemia by temozolomide.

Yingying Zhai^1,2,3, Jingjing Shang^1,2,3, Weiqin Yao^1,2,3, Depei Wu^1,2,3, Chengcheng Fu^1,2,3, Lingzhi Yan^4,5,6.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2022 PMID： 35969250 DOI： 10.1007/s00277-022-04942-4

Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 4.030

Keyword Cloud
References

× No keyword cloud information.

6 in total

1. Successful and durable response of primary CNS T-cell lymphoma to upfront temozolomide monotherapy.

Authors: Meghna Yalamanchi; Akanksha Sharma; Minh Nguyen; Judy Truong; Jose A Carrillo; Naveed Wagle; Jaya M Gill; Santosh Kesari
Journal: Leuk Lymphoma Date: 2021-02-21

2. Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status.

Authors: Delia Kurzwelly; Martin Glas; Patrick Roth; Elke Weimann; Hanns Lohner; Andreas Waha; Martin Schabet; Guido Reifenberger; Michael Weller; Ulrich Herrlinger
Journal: J Neurooncol Date: 2009-10-20 Impact factor: 4.130

3. Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).

Authors: Loïc Renaud; Jean Baptiste Bossard; Benjamin Carpentier; Louis Terriou; Nathalie Cambier; Guillaume Chanteau; Guillaume Escure; Remi Tilmont; Sarah Barbieux; Mathieu Wemeau; Julia Hieulle; Eileen M Boyle; Franck Morschhauser
Journal: Eur J Haematol Date: 2021-06-01 Impact factor: 2.997

Successful eradication of central nervous system infiltration of primary plasma cell leukemia by temozolomide.

1. Successful and durable response of primary CNS T-cell lymphoma to upfront temozolomide monotherapy.

2. Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status.

3. Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).

4. Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications.

Review 5. Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature.

Review 6. Multiple myeloma with central nervous system relapse.